Video

Key Publications on NACT and Targeted therapies in head and neck cancer

Once-a-week versus once-every-3-weeks Cisplatin chemoradiation for locally advanced head and neck cancer: A phase III randomized noninferiority trial

Chairpersons :

Alok Thakar, Krishnakumar Thankappan, K. S. Gopinath

Reviewer :

Vanita Norohna